Oral Presentation

[30-416-pm] Circulatory system 1

Sat. Mar 30, 2024 3:30 PM - 4:30 PM [Room 416] Conference Center 416 (4F)

Chair: Masato Hosokawa, Naoki Sotogaku

+Add all to schedule

3:30 PM - 3:42 PM

[30-416-pm11S] Role of IKs channels in sepsis-induced abnormal cardiac electrical activity

○Kazuki Kimpara¹, Takara Nomaguchi¹, Nozomi Hattori¹, Masami Kodama¹, Yasuhide Watanabe¹, Satoshi Shimizu¹, Shushi Nagamori², Kazuho Sakamoto¹, Junko Kurokawa¹ (1. Facul. Pharm. Sci., Univ. Shizuoka, 2. Dept. Lab. Med. The Jikei Univ. Sch. Med)

3:42 PM - 3:54 PM

[30-416-pm12S] Extract from Sprout of Polygonum Sachalinense Suppressed Systolic Dysfunction after Myocardial Infarction

○Yuto Suzuki¹, Tatsuya Morimoto^1,2,3, Yoiti Sunagawa^1,2,3, Masahumi Funamoto^1,2, Tatsuya Maekawa¹, Koji Hasegawa^1,2,3, Toshihide Hamabe^1,2,3, Yasufumi Katanasaka^1,2,3 (1. Mol. Med., Pharm. Sci., Univ. of Shizuoka, 2. NHO. Kyoto Med. Ctr., 3. Shizuoka Gen. Hosp.)

3:54 PM - 4:06 PM

[30-416-pm13] PRMT5 promotes cardiomyocyte hypertrophy via enhancement of p300 histone acetyltransferase activity

○Yasufumi Katanasaka^1,2,3, Mikuto Tojima¹, Ryuya Naruta¹, Yuto Kawase¹, Toshihide Hamabe¹, Yoichi Sunagawa^1,2,3, Koji Hasegawa², Tatsuya Morimoto^1,2,3 (1. Sch. Pharm. Sci., Univ. of Shizuoka, 2. NHO Kyoto Med. Centr., 3. Shizuoka General Hosp.)

4:06 PM - 4:18 PM

[30-416-pm14S] YAP activation in cardiomyocytes induces restoration of cardiac function after myocarditis.

○yusuke kametani¹, shota suzuki¹, ayaka umeda¹, kosuke nishinaka¹, kaho egawa¹, shota tanaka¹, yoshiaki okada¹, masanori obana¹, yasushi fujio¹ (1. Grad. Sch. Pharm. Sci., Osaka Univ.)

4:18 PM - 4:30 PM

[30-416-pm15S] The novel Curcumin formulation curcuRouge inhibits systolic dysfunction in myocardial infarction model rats

○Masaru Sudo¹, Hidmichi Takai¹, Yoichi Sunagawa^1,2,3, Masafumi Funamoto^1,2, Yuto Kawase¹, Ryuya Naruta¹, Yasufumi Katanasaka^1,2,3, Toshihide Hamabe^1,2,3, Atsushi Imaizumi⁴, Tadashi Hashimoto⁴, Kozi Hasagawa^1,2, Tatsuya Morimoto^1,2,3 (1. Mol.Med., Pharm.Sci., Univ. of Shizuoka, 2. NHO. Kyoto Med. Ctr., 3. Shizuoka Gen. Hosp., 4. Therabiopharma Corp.)

Session information